needed effects
abacavir
dolutegravir
lamivudine
unwanted side effects
medical attention
following side effects
taking abacavir
dolutegravir
lamivudine
check
doctor
abacavir
lamivudine side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
common side effects
insomnia
headache
fatigue
nausea
dizziness
side effects
patients with abacavir hypersensitivity
nausea
vomiting
diarrhea
fever
lethargy
rash
hypersensitivity reactions
abacavir
dolutegravir
common features
fever
rash with other symptoms
multi-organ involvement
time
onset
days for both abacavir
dolutegravir-associated reactions
fatal hypersensitivity reactions
abacavir
such reactions
multi-organ failure
anaphylaxis
first weeks of abacavir therapy
abacavir hypersensitivity reactions
time during therapy
patients with the human leukocyte antigen subtype b *
hla-b *
allele
higher risk of abacavir hypersensitivity reactions
such reactions
patients without the hla-b
allele
abacavir hypersensitivity
patients in clinical trials with abacavir-containing products
patients
hla-b
allele
incidence
suspected abacavir hypersensitivity reactions
clinical trials
hla-b
carriers
abacavir hypersensitivity reactions
following
following key signs/symptoms
fever
rash
gastrointestinal symptoms
including nausea
vomiting
diarrhea
abdominal pain
constitutional symptoms
including
generalized malaise
fatigue
achiness
respiratory symptoms
including dyspnea
cough
pharyngitis
reactions
fever
rash
reactions
fever
rash
signs/symptoms
patients with hypersensitivity reaction
rash
nausea
vomiting
diarrhea
abdominal pain
dyspnea
cough
fever
fatigue/lethargy
malaise
headache
elevated liver function tests
myalgia
other signs/symptoms of hypersensitivity
mouth ulceration
sore throat
adult respiratory distress syndrome
respiratory failure
edema
lymphadenopathy
hypotension
conjunctivitis
anaphylaxis
paresthesia
lymphopenia
hepatitis
liver failure
myolysis
arthralgia
elevated creatine phosphokinase
elevated creatinine
renal failure
abnormal chest x-ray findings
infiltrates
death
symptoms of abacavir hypersensitivity reaction
continued therapy
abacavir
restarting abacavir after a hypersensitivity reaction
severe symptoms within hours
life-threatening hypotension
death
life-threatening reactions
hours
restarting abacavir in patients
reasons
symptoms of hypersensitivity
key symptom of hypersensitivity
hypersensitivityfrequency
hypersensitivity reaction
rash
severe liver effects
abacavir
lamivudine
postmarketing reports
sensitization reactions
including anaphylaxis
abacavir
hypersensitivity reactions
including fever
rash
generalized malaise
fatigue
achiness
nausea
vomiting
diarrhea
abdominal pain
pharyngitis
dyspnea
cough
lethargy
headache
myalgia
myolysis
edema
abnormal chest x-ray findings
localized infiltrates
arthralgia
paresthesia
anaphylaxis
hepatitis
liver failure
renal failure
hypotension
sore throat
adult respiratory distress syndrome
respiratory failure
death
lymphadenopathy
mucous membrane lesions
conjunctivitis
mouth ulcerations
erythema multiforme
elevated liver function tests
elevated creatine phosphokinase
elevated creatinine
lymphopenia
dolutegravir
frequency
hypersensitivity reactions
rash
constitutional findings
organ dysfunction
including liver injury
alt abnormalities
elevated ast
elevated alt
ast abnormalitiesuncommon
hepatitisabacavir
lamivudine
frequency
liver function test abnormalities
steatosisabacavir
frequency
liver function test abnormalities
elevated liver chemistries
ast
alt
alkaline phosphatase
bilirubin
dolutegravir
frequency
transaminase elevations
immune reconstitution syndromelamivudine
frequency
elevated bilirubin
hepatic decompensation
severe acute exacerbations of hepatitis
grade
grade
elevations in ast
therapy-naive patients
week grade
grade
elevations in alt
therapy-naive patients
week in general
laboratory abnormalities
therapy-experienced patients
rates of ast
alt abnormalities
patients
hepatitis b
c virus
hbv
hcv
alt abnormalities
grade
hiv/hcv-coinfected patients
hiv-monoinfected patients
lactic acidosis
steatosis
including
fatal cases
use of nucleoside analogs
transaminase elevations
immune reconstitution syndrome
hepatitis b reactivation in some patients
underlying hepatitis b
c
antihepatitis therapy
hepatic decompensation
patients
hiv
hcv
receiving combination
antiretroviral therapy for hiv
interferon alfa
ribavirin
severe acute exacerbations of hepatitis
patients with hepatitis b after discontinuation of lamivudine
nausea
diarrheacommon
elevated lipase
abdominal pain
abdominal distention
abdominal discomfort
dyspepsia
flatulence
gastroesophageal reflux disease
upper abdominal pain
vomitingrare
pancreatitisabacavir
lamivudine
postmarketing reports
stomatitisabacavir
postmarketing reports
pancreatitis
lamivudine
frequency
elevated lipase-postmarketing reports
elevated amylase
pancreatitis
grade
grade
elevations in lipase
therapy-naive patients
week in general
laboratory abnormalities
therapy-experienced patients
hyperglycemiauncommon
hypertriglyceridemiafrequency
anorexia
lipid values
including cholesterol
high-density lipoprotein
hdl
cholesterol
low-density lipoprotein
ldl
cholesterol
triglycerides
abacavir
lamivudine
frequency
lactic acidosis-postmarketing reports
hyperlactemia
anorexia
abacavir
frequency
elevated blood glucose
elevated triglycerides-postmarketing reports
hyperlactatemia
lactic acidosis
lamivudine
postmarketing reports
hyperlactatemia
lactic acidosis
combination
antiretroviral therapy
frequency
redistribution/accumulation of body fat
including
central obesity
dorsocervical fat enlargement
peripheral wasting
facial wasting
breast enlargement
cushingoid appearance
metabolic abnormalities
hypertriglyceridemia
hypercholesterolemia
insulin resistance
hyperglycemia
hyperlactatemia
grade
grade hyperglycemia
therapy-naive patients
week in general
laboratory abnormalities
therapy-experienced patients
lactic acidosis
steatosis
including
fatal cases
use of nucleoside analogs
redistribution/accumulation of body fat
antiretroviral therapy
causality
grade
grade
elevations in cpk
therapy-naive patients
week in general
laboratory abnormalities
therapy-experienced patients
asymptomatic cpk elevations
exercise
dolutegravir
elevated creatine phosphokinase
cpk
arthralgiafrequency
myositisrare
rhabdomyolysisabacavir
lamivudine
postmarketing reports
muscle weakness
elevated cpkabacavir
frequency
elevated cpkdolutegravir
frequency
asymptomatic cpk elevationslamivudine
postmarketing reports
muscle disorders
arthralgia
rhabdomyolysis
combination
antiretroviral therapy
frequency
osteonecrosis
grade
grade
reductions in total neutrophils
therapy-naive patients
week in general
laboratory abnormalities
therapy-experienced patients
decreased total neutrophilsabacavir
lamivudine
postmarketing reports
aplastic anemia
anemia
including
pure red cell aplasia
severe anemias
therapy
lymphadenopathy
splenomegalyabacavir
anemia
neutropenia-frequency
thrombocytopenia
low wbc countlamivudine
thrombocytopenia-postmarketing reports
pure red cell aplasia
suicidal ideation
attempt
behavior
completion
patients with history of depression
other psychiatric illness
insomniacommon
depression
abnormal dreams
nightmare
sleep disorderuncommon
suicidal ideation
suicide attemptfrequency
suicidal behavior
suicide completion
headachecommon
dizziness
somnolence
lethargyabacavir
lamivudine
postmarketing reports
paresthesia
peripheral neuropathy
seizures
fatiguecommon
fever
asthenia
malaiseabacavir
lamivudine
postmarketing reports
weakness
suspected stevens-johnson syndrome
sjs
toxic epidermal necrolysis
patients
using abacavir
combination with agents
sjs
cases of erythema multiforme
sjs
abacavir hypersensitivity
rash
rash
generalized rash
macular rash
maculopapular rash
pruritic rash
drug eruption
pruritus
alopeciaabacavir
lamivudine
postmarketing reports
urticaria
alopecia
erythema multiformeabacavir
postmarketing reports
rash without systemic symptoms
erythema multiforme
stevens-johnson syndrome
toxic epidermal necrolysis
lamivudine
postmarketing reports
alopecia
frequency
renal impairment
serum creatinine
inhibition of tubular secretion of creatinine
dolutegravir
serum creatinine
inhibition of tubular secretion of creatinine
affecting
affecting renal glomerular function
increased serum creatinine
first weeks of therapy
weeks
trial
mean change from baseline of mg/dl
range
mg/dl
weeks of therapy in therapy-naive patients
creatinine increases
therapy-experienced patients
immune reconstitution/reactivation syndromefrequency
autoimmune disorders in the setting of immune reconstitution
graves
disease
polymyositis
guillain-barre syndrome
coughabacavir
lamivudine
postmarketing reports
abnormal breath sounds/wheezing
nasal symptoms
observational study
rate of mi in patients on combination
antiretroviral therapy
increased risk of mi with the use of abacavir within the previous months
sponsor-conducted pooled analysis of clinical trials
excess risk of mi in abacavir-treated patients
control subjects
available data from the observational cohort
clinical trials
abacavir
frequency
myocardial infarction
mi
side effects of triumeq
fda
healthcare professional for medical advice
dark urine
general tiredness
weakness
light-colored stools
nausea and vomiting
stomach pain
yellow eyes
skin
stomach pain
discomfort
blistering
peeling
loosening of the skin
bloody urine
blurred vision
burning
crawling
itching
numbness
prickling
pins
needles
tingling feelings
burning
itching eyes
chills
confusion
cough
decreased appetite
decreased frequency
amount of urine
diarrhea
difficulty with moving
difficulty with swallowing
discharge
excessive tearing
dizziness
dizziness
faintness
lightheadedness
getting
lying
sitting position
fainting
fast heartbeat
fast, shallow breathing
fever
general feeling of discomfort
illness
headache
hives
itching
rash
increased thirst
muscle pain
hive-like swelling on the face
eyelids
lips
tongue
throat
hands
legs
feet
sex organs
light-colored stools
side pain
muscle pain
cramping
stiffness
puffiness
swelling of the eyelids
eyes
face
lips
tongue
rapid, shallow breathing
red, irritated eyes
redness
pain
swelling of the eye
eyelid
inner lining of the eyelid
sleepiness
sore throat
sores
ulcers
white spots in the mouth
lips
stomach pain, continuing
sweating
swelling of the face
fingers
lower legs
swelling
puffiness of the face
tender lymph glands in the neck
armpit
groin
tightness in the chest
troubled breathing
unusual drowsiness
dullness
tiredness
weakness
feeling of sluggishness
weight gain
discouragement
feeling
irritability
loss of interest
pleasure
trouble concentrating
trouble sleeping
acid
sour stomach
belching
difficulty with moving
excess air
gas in the stomach
intestines
bloated feeling
heartburn
indigestion
passing gas
pressure in the stomach
sleepiness
unusual drowsiness
stomach upset
swelling of the abdominal
stomach area
weight loss
hair loss
thinning of the hair
weight gain
neck
breast
waist